Related references
Note: Only part of the references are listed.Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Ibrahim Yakoub-Agha et al.
HAEMATOLOGICA (2020)
Macrophage-tumor cell interaction promotes ATRT progression and chemoresistance
Viktoria Melcher et al.
ACTA NEUROPATHOLOGICA (2020)
Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333
Alyssa T. Reddy et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy
Monica S. Thakar et al.
FRONTIERS IN ONCOLOGY (2020)
Invaders Exposed: Understanding and Targeting Tumor Cell Invasion in Diffuse Intrinsic Pontine Glioma
T. A. Kluiver et al.
FRONTIERS IN ONCOLOGY (2020)
Shaping Our Understanding of Medulloblastoma: A Bibliometric Analysis of the 100 Most Cited Articles
Victor M. Lu et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2020)
The Role of Immune Checkpoints after Cellular Therapy
Friederike Schmitz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
Laura K. Donovan et al.
NATURE MEDICINE (2020)
B7-H3-Targeted CAR-T Cells Exhibit Potent Antitumor Effects on Hematologic and Solid Tumors
Zongliang Zhang et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases
Costas D. Arvanitis et al.
NATURE REVIEWS CANCER (2020)
Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy
Nicole A. P. Lieberman et al.
NEURO-ONCOLOGY (2019)
Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: Cure at a cost
Michal Zapotocky et al.
CANCER (2019)
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
Hongwei Du et al.
CANCER CELL (2019)
Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma
Thomas E. Merchant et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Risks and Benefits of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Cancer: A Systematic Review and Meta-Analysis
Emma J. M. Grigor et al.
TRANSFUSION MEDICINE REVIEWS (2019)
Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial
Santhosh A. Upadhyaya et al.
NEURO-ONCOLOGY (2019)
Tumor Mesenchymal Stromal Cells Regulate Cell Migration of Atypical Teratoid Rhabdoid Tumor through Exosome-Mediated miR155/SMARCA4 Pathway
Yi-Ping Yang et al.
CANCERS (2019)
CAR T cells for brain tumors: Lessons learned and road ahead
David Akhavan et al.
IMMUNOLOGICAL REVIEWS (2019)
Understanding the Mechanisms of Resistance to CAR T-Cell Therapy in Malignancies
Jiali Cheng et al.
FRONTIERS IN ONCOLOGY (2019)
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Daniel W. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management
Jennifer N. Brudno et al.
BLOOD REVIEWS (2019)
Trends in Pediatric Central Nervous System Tumor Incidence in the United States, 1998-2013
Diana R. Withrow et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
Targeting cancers through TCR-peptide/MHC interactions
Qinghua He et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
CAR T Cell Therapy for Hematological Malignancies
Xin Yang et al.
CURRENT MEDICAL SCIENCE (2019)
Chimeric Antigen Receptor-Natural Killer Cells: The Future of Cancer Immunotherapy
Sana Habib et al.
OCHSNER JOURNAL (2019)
Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis
Stephen J. Gaudino et al.
FRONTIERS IN IMMUNOLOGY (2019)
Current Progress in CAR-T Cell Therapy for Solid Tumors
Shuo Ma et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
Kevin Bielamowicz et al.
NEURO-ONCOLOGY (2018)
CD70, a novel target of CAR T-cell therapy for gliomas
Linchun Jin et al.
NEURO-ONCOLOGY (2018)
ProteomicsDB
Tobias Schmidt et al.
NUCLEIC ACIDS RESEARCH (2018)
Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma
Jeroen F. Vermeulen et al.
ONCOIMMUNOLOGY (2018)
Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma
Domenico Orlando et al.
CANCER RESEARCH (2018)
Leptomeningeal Metastases
Jerome J. Graber et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways
Yaling Qi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Outcomes After Reirradiation for Recurrent Pediatric Intracranial Ependymoma
Derek S. Tsang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
High programmed cell death 1 ligand-1 expression: association with CD8+T-cell infiltration and poor prognosis in human medulloblastoma
Daiki Murata et al.
JOURNAL OF NEUROSURGERY (2018)
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
Christopher W. Mount et al.
NATURE MEDICINE (2018)
Specific expression of PD-L1 in RELA-fusion supratentorial ependymoma: Implications for PD-1-targeted therapy
Davis A. Witt et al.
PEDIATRIC BLOOD & CANCER (2018)
Subgroup-specific immune and stromal microenvironment in medulloblastoma
Michael Bockmayr et al.
ONCOIMMUNOLOGY (2018)
Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
Zhongzhen Yi et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Durable regression of Medulloblastoma after regional and intravenous delivery of anti-HER2 chimeric antigen receptor T cells
Anandani Nellan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma
Grant L. Lin et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2018)
In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example
Hana Golan et al.
STEM CELL REPORTS (2018)
Pediatric high-grade glioma: biologically and clinically in need of new thinking
Chris Jones et al.
NEURO-ONCOLOGY (2017)
Pediatric high-grade glioma: current molecular landscape and therapeutic approaches
Steve Braunstein et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors
Shanta M. Messerli et al.
MOLECULAR CANCER RESEARCH (2017)
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma
Andras Heczey et al.
MOLECULAR THERAPY (2017)
Cancer stem cells revisited
Eduard Batlle et al.
NATURE MEDICINE (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
Marc Damelin et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Chimeric antigen receptor T-cell therapy for glioblastoma
Analiz Rodriguez et al.
TRANSLATIONAL RESEARCH (2017)
Potential New Therapies for Pediatric Diffuse Intrinsic Pontine Glioma
Wenyong Long et al.
FRONTIERS IN PHARMACOLOGY (2017)
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
Hamid R. Mirzaei et al.
FRONTIERS IN IMMUNOLOGY (2017)
Trial Watch: Adoptively transferred cells for anticancer immunotherapy
Carole Fournier et al.
ONCOIMMUNOLOGY (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG)
Ho-Shin Gwak et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Immunotherapy for Pediatric Brain Tumors
Elias J. Sayour et al.
BRAIN SCIENCES (2017)
Assessment of Programmed Death-Ligand 1 Expression and Tumor-Associated Immune Cells in Pediatric Cancer Tissues
Robbie G. Majzner et al.
CANCER (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Inhibition of the B7-H3 immune checkpoint limits tumor growth by enhancing cytotoxic lymphocyte function
Young-hee Lee et al.
CELL RESEARCH (2017)
Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma
Christina D. Pham et al.
CLINICAL CANCER RESEARCH (2016)
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Vijay Ramaswamy et al.
ACTA NEUROPATHOLOGICA (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
NKG2D ligand expression in pediatric brain tumors
Kristen Haberthur et al.
CANCER BIOLOGY & THERAPY (2016)
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors
Jonathon Torchia et al.
CANCER CELL (2016)
Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
Pascal D. Johann et al.
CANCER CELL (2016)
Assessment of Brain Tumor Response: RANO and Its Offspring
Sylvia C. Eisele et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape (Publication with Expression of Concern. See vol. 129, pg. 3464, 2019)
Meenakshi Hegde et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia
Noelle V. Frey et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)
CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains
Satoshi Shiina et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Know your neighbors: Different tumor microenvironments have implications in immunotherapeutic targeting strategies across MB subgroups
Christina D. Pham et al.
ONCOIMMUNOLOGY (2016)
Atypical teratoid/rhabdoid tumors: challenges and search for solutions
Ahitagni Biswas et al.
CANCER MANAGEMENT AND RESEARCH (2016)
An Optimized GD2-Targeting Retroviral Cassette for More Potent and Safer Cellular Therapy of Neuroblastoma and Other Cancers
Simon Thomas et al.
PLOS ONE (2016)
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation
Xiaoou Zhou et al.
BLOOD (2015)
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
Kristian W. Pajtler et al.
CANCER CELL (2015)
Immunotherapy response assessment in neuro-oncology: a report of the RANO working group
Hideho Okada et al.
LANCET ONCOLOGY (2015)
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis
Jonathon Torchia et al.
LANCET ONCOLOGY (2015)
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
Adrienne H. Long et al.
NATURE MEDICINE (2015)
The pharmacology of second-generation chimeric antigen receptors
Sjoukje J. C. van der Stegen et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma
Andrea M. Griesinger et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas
Ashley S. Margol et al.
CLINICAL CANCER RESEARCH (2015)
Postnatal Growth of the Human Pons: A Morphometric and Immunohistochemical Analysis
Matthew C. Tate et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2015)
Preclinical evaluation of dasatinib alone and in combination with cabozantinib for the treatment of diffuse intrinsic pontine glioma
Nathalene Truffaux et al.
NEURO-ONCOLOGY (2015)
Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
Faviel F. Gonzalez-Galarza et al.
NUCLEIC ACIDS RESEARCH (2015)
Glioblastoma: Defining Tumor Niches
Dolores Hambardzumyan et al.
TRENDS IN CANCER (2015)
Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma
Lindsey M. Hoffman et al.
ACTA NEUROPATHOLOGICA (2014)
Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
Shannon L. Maude et al.
CANCER JOURNAL (2014)
Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas
Ian F. Pollack et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
Suzanne L. Topalian et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Mass-spectrometry-based draft of the human proteome
Mathias Wilhelm et al.
NATURE (2014)
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
Pawel Buczkowicz et al.
NATURE GENETICS (2014)
Intensive Induction Chemotherapy Followed by Myeloablative Chemotherapy With Autologous Hematopoietic Progenitor Cell Rescue for Young Children Newly-Diagnosed With Central Nervous System Atypical Teratoid/Rhabdoid Tumors: The Head Start III Experience
Wafik Zaky et al.
PEDIATRIC BLOOD & CANCER (2014)
Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation
Kosuke Funato et al.
SCIENCE (2014)
The inducible caspase-9 suicide gene system as a safety switch to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells
Tessa Gargett et al.
FRONTIERS IN PHARMACOLOGY (2014)
Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge
Dominik Sturm et al.
NATURE REVIEWS CANCER (2014)
Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation
Winnie W. Pong et al.
ANNALS OF NEUROLOGY (2013)
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
David T. Teachey et al.
BLOOD (2013)
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Nataliya Zhukova et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
High-Risk Medulloblastoma: A Pediatric Oncology Group Randomized Trial of Chemotherapy Before or After Radiation Therapy (POG 9031)
Nancy J. Tarbell et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Characterization of Distinct Immunophenotypes across Pediatric Brain Tumor Types
Andrea M. Griesinger et al.
JOURNAL OF IMMUNOLOGY (2013)
Blood-brain barrier structure and function and the challenges for CNS drug delivery
N. Joan Abbott
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy
Jacky T. Yeung et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
Zhiping Zhou et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Kevin K. H. Chow et al.
MOLECULAR THERAPY (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Re-irradiation with hypo-fractionated stereotactic robotic radiotherapy for salvage in adult patients with brainstem glioma
Sridhar P. Susheela et al.
ECANCERMEDICALSCIENCE (2013)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
Dong-Anh Khuong-Quang et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
Immune Cell Infiltrates in Atypical Teratoid/Rhabdoid Tumors
Jian-Qiang Lu et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2012)
Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis
Daniela L. Buscariollo et al.
CANCER (2012)
Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system
Christelle Dufour et al.
CANCER (2012)
Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
Dominik Sturm et al.
CANCER CELL (2012)
Stem-like Tumor-Initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine-Redirected T Cells
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2012)
Central nervous system atypical teratoid rhabdoid tumours: The Canadian Paediatric Brain Tumour Consortium experience
L. Lafay-Cousin et al.
EUROPEAN JOURNAL OF CANCER (2012)
The incidence of medulloblastomas and primitive neurectodermal tumours in adults and children
Nicolas R. Smoll et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial
Birgitta Lannering et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Treatment of recurrent diffuse intrinsic pontine glioma: the MD Anderson Cancer Center experience
Johannes E. Wolff et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
Diffusion tensor imaging of white matter tract evolution over the lifespan
C. Lebel et al.
NEUROIMAGE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Immunotherapy targets in pediatric cancer
Rimas J. Orentas et al.
FRONTIERS IN ONCOLOGY (2012)
Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct
Paul A. Northcott et al.
ACTA NEUROPATHOLOGICA (2011)
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
Chrystal U. Louis et al.
BLOOD (2011)
Delineation of Two Clinically and Molecularly Distinct Subgroups of Posterior Fossa Ependymoma
Hendrik Witt et al.
CANCER CELL (2011)
Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma
Ingrid Slade et al.
FAMILIAL CANCER (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
David W. Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Genome-Wide Analyses Identify Recurrent Amplifications of Receptor Tyrosine Kinases and Cell-Cycle Regulatory Genes in Diffuse Intrinsic Pontine Glioma
Barbara S. Paugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature
Mariela C. Cocce et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
The biology of cancer testis antigens: Putative function, regulation and therapeutic potential
Elisabetta Fratta et al.
MOLECULAR ONCOLOGY (2011)
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
Kenneth J. Cohen et al.
NEURO-ONCOLOGY (2011)
Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma
Michelle Monje et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Intensive Chemotherapy Improves Survival in Pediatric High-Grade Glioma After Gross Total Resection: Results of the HIT-gBM-c Protocol
Johannes E. A. Wolff et al.
CANCER (2010)
OTX2 Is Critical for the Maintenance and Progression of Shh-Independent Medulloblastomas
David C. Adamson et al.
CANCER RESEARCH (2010)
4-1BB and CD28 Signaling Plays a Synergistic Role in Redirecting Umbilical Cord Blood T Cells Against B-Cell Malignancies
Syam Tammana et al.
HUMAN GENE THERAPY (2010)
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
Barbara S. Paugh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Molecular Staging of Intracranial Ependymoma in Children and Adults
Andrey Korshunov et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Incomplete penetrance of the predisposition to medulloblastoma associated with germ-line SUFU mutations
Laurence Brugieres et al.
JOURNAL OF MEDICAL GENETICS (2010)
High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system
Theodore Nicolaides et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Identification of a SUFU Germline Mutation in a Family With Gorlin Syndrome
L. Pastorino et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Recognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8+ Cytolytic T Cells
Christine E. Brown et al.
CANCER RESEARCH (2009)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic Medulloblastoma
Lorenza Gandola et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor
Susan N. Chi et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma
Paul A. Northcott et al.
NATURE GENETICS (2009)
The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial
Helena M. Linge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy
Jian Gang Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas
Y. Komohara et al.
JOURNAL OF PATHOLOGY (2008)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin A. Pule et al.
NATURE MEDICINE (2008)
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Marcel Kool et al.
PLOS ONE (2008)
The epidermal growth factor receptor: from development to tumorigenesis
Maria Sibilia et al.
DIFFERENTIATION (2007)
Regression of experimental medulloblastoma following transfer of HER2-specific T cells
Nabil Ahmed et al.
CANCER RESEARCH (2007)
Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth
Girish C. Daginakatte et al.
HUMAN MOLECULAR GENETICS (2007)
Molecular pathogenesis of pediatric astrocytic tumors
Mitsutoshi Nakamura et al.
NEURO-ONCOLOGY (2007)
Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood:: results from the Children's Cancer Group 945 cohort
Ian F. Pollack et al.
JOURNAL OF NEUROSURGERY (2006)
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J. Packer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Advances toward an understanding of brainstem gliomas
SS Donaldson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas
T de Haas et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells
N van Baren et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma
WHJ Kruit et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy
RE Taylor et al.
EUROPEAN JOURNAL OF CANCER (2005)
GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors
K Gijsbers et al.
EXPERIMENTAL CELL RESEARCH (2005)
Murine B7-H3 is a negative regulator of T cells
DVR Prasad et al.
JOURNAL OF IMMUNOLOGY (2004)
Medulloblastoma: Present concepts of stratification into risk groups
RJ Packer et al.
PEDIATRIC NEUROSURGERY (2003)
Mutations in SUFU predispose to medulloblastoma
MD Taylor et al.
NATURE GENETICS (2002)
B7-H3:: A costimulatory molecule for T cell activation and IFN-γ production
AI Chapoval et al.
NATURE IMMUNOLOGY (2001)
Share Paper
